Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis

Journal of Crohn's and Colitis

Volumn 7, Issue 2, 2013, Pages 142-149

  Eshuis, Emma J ^a   Al Saady, Rana L ^a   Stokkers, Pieter C F ^a   Ponsioen, Cyriel Y ^a   Tanis, Pieter J ^a   Bemelman, Willem A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Complications; Ileal pouch anal anastomosis; Infliximab; IPAA; Pelvic sepsis; Ulcerative colitis

Indexed keywords

INFLIXIMAB;

ABSCESS; ADULT; ARTICLE; ATTRIBUTABLE RISK; CLINICAL ARTICLE; COLON RESECTION; CONTROLLED STUDY; FEMALE; HUMAN; ILEOANAL ANASTOMOSIS; ILEUM POUCH; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; SEPSIS; ULCERATIVE COLITIS;

ABSCESS; ADULT; ANASTOMOTIC LEAK; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84872497005     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.03.013     Document Type: Article

References (15)

1. Gisbert J.P., Gonzalez-Lama Y., Mate J. Systematic review: infliximab therapy in ulcerative colitis. Aliment Pharmacol Ther 2007, 25:19-37.
2. Ferrante M., D'Hoore A., Vermeire S., Declerck S., Noman M., Van Assche G., et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009, 15:1062-1070.
3. Schluender S.J., Ippoliti A., Dubinsky M., Vasiliauskas E.A., Papadakis K.A., Mei L., et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?. Dis Colon Rectum 2007, 50:1747-1753.
4. Selvasekar C.R., Cima R.R., Larson D.W., Dozois E.J., Harrington J.R., Harmsen W.S., et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007, 204:956-962.
5. Mor I.J., Vogel J.D., da Luz M.A., Shen B., Hammel J., Remzi F.H. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008, 51:1202-1207.
6. Travis S.P., Stange E.F., Lémann M., Oresland T., Bemelman W.A., Chowers Y., et al. European evidence-based consensus on the management of ulcerative colitis: Current management. J Crohns Colitis 2008, 2:24-62.
7. Williamson M.E., Lewis W.G., Sagar P.M., Holdsworth P.J., Johnston D. One-stage restorative proctocolectomy without temporary ileostomy for ulcerative colitis: a note of caution. Dis Colon Rectum 1997, 40:1019-1022.
8. Hueting W.E., Buskens E., van der Tweel I., Gooszen H.G., van Laarhoven C.J. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg 2005, 22:69-79.
9. Kunitake H., Hodin R., Shellito P.C., Sands B.E., Korzenik J., Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008, 12:1730-1736.
10. Gainsbury M.L., Chu D.I., Howard L.A., Coukos J.A., Farraye F.A., Stucchi A.F., et al. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. J Gastrointest Surg 2011, 15:397-403.
11. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003, 3:745-756.
12. Tracey D., Klareskog L., Sasso E.H., Salfeld J.G., Tak P.P. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008, 117:244-279.
13. Jarnerot G., Hertervig E., Friis-Liby I., Blomquist L., Karlén P., Grännö C., et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005, 128:1805-1811.
14. Bordeianou L., Kunitake H., Shellito P., Hodin R. Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery. Int J Colorectal Dis 2010, 25:401-404.
15. Yang Z., Wu Q., Wu K., Fan D. Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2010, 31:486-492.